Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Aptus Endosystems
Aptus Endosystems develops advanced technology for endovascular treatment of aortic aneurysm disease.
Sector
Subsector
Location
total rounds
total raised
HighLife
HighLife is a company that focuses on Transcatheter Mitral Valve Replacement (TMVR).
Sector
Subsector
Keywords
Location
total rounds
total raised
Thubrikar Aortic Valve
Thubrikar Aortic Valve develops a next-generation medical device for aortic stenosis.
Sector
Subsector
Keywords
Location
total rounds
total raised
Cardiac Dimensions
Cardiac Dimensions develops medical devices for heart failure and related conditions.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Edwards Lifesciences
announced date
Financials
Funding Rounds12
Number of Funding Rounds
Money Raised
Their latest funding was raised on 02.02.2018. Their latest round Venture - Series Unknown
Qiming Venture Partners
Qiming Venture Partners is a leading China-based venture capital firm that invests in technology, consumer, and healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors13
Number of lead investors
Number of investors
Forbion
Netherlands-based venture capital firm investing in life sciences and MedTech companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Martien van Osch
For this reason he splits his time between operational activities and the finance function. In terms of investment focus, Martien spearheads the medical device related activities at Forbion and as such was responsible for the recent exit of Pathway Medical Technologies, Inc., sold to Bayer Medrad in 2011 for USD 125 million. He currently actively contributes to the boards of Circulite, Inc., Mitralign Inc., PneumRx, Inc and Santaris Pharma AS. His experience in the life sciences industry also includes prior non-executive board positions at Cambridge Drug Discovery Ltd (sold to Biofocus Plc in 2001), Impella Cardiosystems (sold to Abiomed, Inc. in 2005), Acadia Pharmaceuticals (IPO on Nasdaq in 2004) and Flowmedica, Inc. (sold to Angiodynamics in 2009). After joining ABN AMRO as a Senior Analyst in Group Planning and Control, in 1998 Martien switched to ABN AMRO Capital and decided to join the newly formed life sciences team in 2000 as an investment director. There he developed the Medical Devices investment strategy e.g. by joining the ATI (Accelerating Technologies, Inc.) incubator initiative, focused on start-ups in Interventional Cardiology.
current job
Palisade Capital Management
Palisade Capital Management is a registered investment advisor that manages assets for institutions and high net worth companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Oakwood Medical Investors
Oakwood Medical Investors is a life sciences venture capital fund.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Rick Geoffrion
Mr. Geoffrion has over 25 years of management experience in the medical device industry and more than 20 years in the cardiovascular space. A co-founder of Mitralign, he previously led company foundation, deal structuring and served as the early stage CEO for five other medical device companies. In addition, he guided the recapitalization and redirection of two other successful medical device companies. Mr. Geoffrion currently sits on the Board of Directors of CircuLite, Inc. and Mitralign, Inc. He has also served as the Chairman of Impella CardioSystems AG, CircuLite and FlowMedica, Inc. He holds a BSME and an MBA from the University of Connecticut.
current job
organization founded
Rick Geoffrion
Employee Profiles5
Susan P Stimson
Director of Marketing and Clinical Research
